Business Wire

NY-ENERGY-IMPACT

5.4.2022 09:02:08 CEST | Business Wire | Press release

Share
EIP Announces APG and Mainova Join Global Coalition

Energy Impact Partners (EIP), a global venture capital firm leading the transition to a sustainable future, announced today APG Asset Management (APG) and Mainova AG (Mainova) joined the firms’ growing global coalition of industrial partners, which consists of European energy utilities and global financial asset managers. EIP works with its strategic partners in a proprietary model to find, screen and scale technologies that are critical for the global net zero carbon economy. In collaboration with its partner network, EIP shares insights, invests in innovative businesses and stimulates the growth of its portfolio companies.

“Our coalition is focused on accelerating the net zero carbon economy and adding strategic partners such as APG and Mainova are critical to the mission,” said Matthias Dill, CEO & Managing Partner at Energy Impact Partners Europe. “We are thrilled to welcome both companies to our expanding platform and look forward to working with them to scale the key technologies critical for a cleaner future. We thrive on the strength of our network and APG and Mainova will add further leverage to our efforts.”

APG and Mainova join a diverse group of industry leaders across the energy, mobility and sustainability industries including Nysnø Climate Investments, EWE, Galp and the Microsoft Climate Innovation Fund. Their participation in EIP’s global coalition furthers both companies’ commitments and strategies to contribute to innovation and reduce their carbon footprint. APG will join EIP’s ESG advisory board and Mainova will play an active role in the coalition.

“APG is committed to the energy transition in several ways and endorses the importance of long term partnerships such as with EIP’s global coalition. APG’s commitment will contribute to the impact growth of companies relevant to the energy transition thereby contributing to fulfilling society’s urgent need and ambition to become carbon neutral. APG is therefore pleased to formally announce its commitment to EIP,” said Nienke Vledder, Senior Portfolio Manager Private Investments.

“As the leading energy supplier in the Frankfurt metropolitan region, Mainova is constantly looking for new energy solutions that help our clients to become carbon neutral. EIP provides us with intelligent food for thought as well as early access to promising ideas and founders. We are looking forward to taking an active part in EIP’s coalition and to collaborating with innovative startups. They will help us and our customers to successfully get through the energy transition,” said Mainova CEO Dr. Constantin H. Alsheimer.

“EIP has for instance introduced us to Instagrid, a provider of portable power stations. Together with the startup, we have successfully tested their battery power packs. They can replace diesel gensets and thus reduce the carbon footprint of our DSO and street lighting business,” added Simon Wisseler, Senior Project Manager Corporate Strategy and Venture Capital at Mainova.

For more information on EIP, please visit www.energyimpactpartners.com .

About Energy Impact Partners
Energy Impact Partners LP (EIP) is a global venture capital firm leading the transition to a sustainable future. EIP brings together entrepreneurs and the world's most forward-looking energy and industrial companies to advance innovation. With over $2.5 billion in assets under management, EIP invests globally across venture, growth, credit, and infrastructure – and has a team of nearly 70 professionals based in its offices in New York, San Francisco, Palm Beach, London, and Cologne. For more information on EIP, please visit www.energyimpactpartners.com .

About APG
Every day APG is busy with something that already concerns millions of Dutch people and one day will concern millions more: pensions. APG strives to provide a good pension in a livable world for all participants, employers and pension funds. Together we work on a sustainable future in which we do not only look at prosperity, but also at well-being. Because pensions are about people, life and how we live together. So that we, our parents, and our children can enjoy a good income. Today, tomorrow, and beyond. As the largest pension provider in the Netherlands APG looks after the pensions of 4.7 million participants. APG provides executive consultancy, asset management, pension administration, pension communication and employer services. We work for pension funds and employers in the sectors of education, government, construction, cleaning, housing associations, sheltered employment organizations, medical specialists, and architects. APG manages approximately €605billion (February 2022) in pension assets. With approximately 3,000 employees we work from Heerlen, Amsterdam, Brussels, New York, Hong Kong, Shanghai and Beijing.

About Mainova
Mainova is one of the largest regional energy suppliers in Germany and supplies about one million customers in Hesse and neighboring provinces with electricity, gas, district heating and water. Mainova also provides a wide range of energy-related products and services in areas like renewable energy, energy efficiency and e-mobility. Mainova generated around € 2.3 billion in annual revenue in 2020 with approximately 2,900 employees. Mainova was founded in 1998 and is headquartered in Frankfurt am Main, Germany.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye